KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Amortization of Deferred Charges: 2009-2025

Historic Amortization of Deferred Charges for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $16.0 million.

  • Bausch Health Companies' Amortization of Deferred Charges rose 23.08% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.0 million, marking a year-over-year increase of 56.36%. This contributed to the annual value of $55.0 million for FY2024, which is 15.38% down from last year.
  • Bausch Health Companies' Amortization of Deferred Charges amounted to $16.0 million in Q3 2025, which was down 60.98% from $41.0 million recorded in Q2 2025.
  • Bausch Health Companies' Amortization of Deferred Charges' 5-year high stood at $50.0 million during Q2 2022, with a 5-year trough of $11.0 million in Q1 2023.
  • Its 3-year average for Amortization of Deferred Charges is $17.5 million, with a median of $14.0 million in 2024.
  • Per our database at Business Quant, Bausch Health Companies' Amortization of Deferred Charges soared by 316.67% in 2022 and then plummeted by 76.00% in 2023.
  • Over the past 5 years, Bausch Health Companies' Amortization of Deferred Charges (Quarterly) stood at $13.0 million in 2021, then remained steady at $13.0 million in 2022, then grew by 7.69% to $14.0 million in 2023, then remained steady at $14.0 million in 2024, then grew by 23.08% to $16.0 million in 2025.
  • Its Amortization of Deferred Charges was $16.0 million in Q3 2025, compared to $41.0 million in Q2 2025 and $15.0 million in Q1 2025.